Advertisement

Dyslipidemia-Induced Neuropathy in Mice: the Role of oxLDL/LOX-1

  1. Andrea M. Vincent (andreav{at}umich.edu)1,
  2. John M. Hayes1,
  3. Lisa L. McLean1,
  4. Anuradha Vivekanandan-Giri2,
  5. Subramaniam Pennathur2 and
  6. Eva L. Feldman1
  1. 1Department of Neurology
  2. 2Department of Medicine, University of Michigan, Ann Arbor, MI

    Abstract

    Objective: Neuropathy is a frequent and severe complication of diabetes. Multiple metabolic defects in type 2 diabetic patients result in oxidative injury of dorsal root ganglia (DRG) neurons. Our previous work focused on hyperglycemia clearly demonstrates induction of mitochondrial oxidative stress and acute injury in DRG neurons; however, this mechanism is not the only factor that produces neuropathy in vivo. Dyslipidemia also correlates with the development of neuropathy, even in pre-diabetic patients. This study was designed to explore the contribution of dyslipidemia in neuropathy.

    Research Design and Methods: Mice (n=10) were fed a control (10%kcal%fat) or high fat (45%kcal%fat) diet to explore the impact of plasma lipids on the development of neuropathy. We also examined oxidized lipid-mediated injury in cultured DRG neurons from adult rat using oxidized low density lipoproteins (oxLDL).

    Results: Mice on a high fat diet have increased oxLDL and systemic and nerve oxidative stress. They develop nerve conduction velocity (NCV) and sensory deficits prior to impaired glucose tolerance. In vitro, oxLDL lead to severe DRG neuron oxidative stress via interaction with the receptor LOX-1 and subsequent NAD(P)H oxidase activity. Oxidative stress resulting from oxLDL and high glucose is additive.

    Conclusions: Multiple metabolic defects in type 2 diabetes directly injure DRG neurons through different mechanisms that all result in oxidative stress. Dyslipidemia leads to high levels of oxLDL that may injure DRG neurons via LOX-1 and contribute to the development of diabetic neuropathy.

    Footnotes

      • Received January 9, 2009.
      • Accepted June 28, 2009.
    Advertisement